Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. - Caye A; Strullu M; Guidez F; Cassinat B; Gazal S; Fenneteau O; Lainey E; Nouri K; Nakhaei-Rad S; Dvorsky R; Lachenaud J; Pereira S; et al. (Nature genetics, 2015)